Authors: Yee, LJ Tang, YM Gibson, AW Kimberly, R van Leeuwen, DJ Kaslow, RA

Citation: Lj. Yee et al., Interleukin 10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infection, HEPATOLOGY, 33(3), 2001, pp. 708-712

Authors: van den Hazel, SJ Wolfhagen, FHJ van Buuren, HR van de Meeberg, PC van Leeuwen, DJ

Citation: Sj. Van Den Hazel et al., Prospective risk assessment of endoscopic retrograde cholangiography in patients with primary sclerosing cholangitis, ENDOSCOPY, 32(10), 2000, pp. 779-782

Authors: van Leeuwen, DJ Reeders, JWAJ

Citation: Dj. Van Leeuwen et Jwaj. Reeders, Primary sclerosing cholangitis and cholangiocarcinoma as a diagnostic and therapeutic dilemma, ANN ONCOL, 10, 1999, pp. 89-93

Authors: Everson, GT Jensen, DM Craig, JR van Leeuwen, DJ Bain, VG Ehrinpreis, MN Albert, D Joh, T Witt, K

Citation: Gt. Everson et al., Efficacy of interferon treatment for patients with chronic hepatitis C: Comparison of response in cirrhotics, fibrotics, or nonfibrotics, HEPATOLOGY, 30(1), 1999, pp. 271-276

Authors: van Leeuwen, DJ

Citation: Dj. Van Leeuwen, Cost-effectiveness of interferon treatment for hepatitis C, J AM MED A, 281(22), 1999, pp. 2083-2084